Ginkgo Bioworks Holdings Share Holder Equity 2020-2022 | DNA
Ginkgo Bioworks Holdings share holder equity from 2020 to 2022. Share holder equity can be defined as the sum of preferred and common equity items
- Ginkgo Bioworks Holdings share holder equity for the quarter ending March 31, 2022 was $1.614B, a 32180.96% increase year-over-year.
- Ginkgo Bioworks Holdings share holder equity for 2021 was $1.567B, a 233.45% increase from 2020.
- Ginkgo Bioworks Holdings share holder equity for 2020 was $0.47B, a INF% increase from 2019.
- Ginkgo Bioworks Holdings share holder equity for 2019 was $0B, a NAN% decline from .
Ginkgo Bioworks Holdings Annual Share Holder Equity
(Millions of US $) |
| 2021 |
$1,567 |
| 2020 |
$470 |
| 2019 |
$0 |
Ginkgo Bioworks Holdings Quarterly Share Holder Equity
(Millions of US $) |
| 2022-03-31 |
$1,614 |
| 2021-12-31 |
$1,567 |
| 2021-09-30 |
$1,618 |
| 2021-06-30 |
$5 |
| 2021-03-31 |
$5 |
| 2020-12-31 |
|
| 2020-09-30 |
$0 |
| 2019-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$5.561B |
$0.314B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
